CD1d-restricted T cell activation by nonlipidic small molecules. - Wikidata - wikimedia - TriplyDB

CD1d-restricted T cell activation by nonlipidic small molecules.

CD1d-restricted T cell activation by nonlipidic small molecules.

http://www.wikidata.org/entity/Q37535060

about

The role of NKT cells in tumor immunity Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?Donor Unrestricted T Cells: A Shared Human T Cell Response The Extended Family of CD1d-Restricted NKT Cells: Sifting through a Mixed Bag of TCRs, Antigens, and Functions A conserved human T cell population targets mycobacterial antigens presented by CD1b Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor Functional CD1d and/or NKT cell invariant chain transcript in horse, pig, African elephant and guinea pig, but not in ruminants Paucity of CD4+ natural killer T (NKT) lymphocytes in sooty mangabeys is associated with lack of NKT cell depletion after SIV infection.Non-classical natural killer T cells modulate plasmid DNA vaccine antigen expression and vaccine-elicited immune responses by MCP-1 secretion after interaction with a beta2-microglobulin-independent CD1d.Transcriptional control of invariant NKT cell development.Anatomy of CD1-lipid antigen complexes.Exacerbated susceptibility to infection-stimulated immunopathology in CD1d-deficient mice.Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d Invariant NKT Cell Lines Derived from the NOD·H2 Mouse Enhance Autoimmune Thyroiditis.Presentation of lipid antigens by CD1 glycoproteins.dysregulation of CD1d-restricted type ii natural killer T cells leads to spontaneous development of colitis in mice.Recognition of lipid antigens by T cells.Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors.The bovine CD1D gene has an unusual gene structure and is expressed but cannot present α-galactosylceramide with a C26 fatty acid Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer CD1c bypasses lysosomes to present a lipopeptide antigen with 12 amino acids.UVB-induced skin inflammation and cutaneous tissue injury is dependent on the MHC class I-like protein, CD1d The evolved functions of CD1 during infection.CD1a-autoreactive T cells recognize natural skin oils that function as headless antigens.Raising the NKT cell family.Harnessing natural killer T (NKT) cells in human myeloma: progress and challenges.T cells specific for lipid antigens.Immunomodulatory type II natural killer T lymphocytes in health and disease.Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells.Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality?The role of natural killer T cells in B cell malignancies.The preventive role of type 2 NKT cells in the development of type 1 diabetes.Susceptibility to Entamoeba histolytica intestinal infection is related to reduction in natural killer T-lymphocytes in C57BL/6 mice.Activation of human T cells by CD1 and self-lipids.The processing and presentation of lipids and glycolipids to the immune system.Mechanisms and Consequences of Antigen Presentation by CD1.Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination.Alternative spliced CD1d transcripts in human bronchial epithelial cells.CD1c presentation of synthetic glycolipid antigens with foreign alkyl branching motifs.

P2860

Q24648939-58518748-0EC9-473F-A569-653193ED25E8 Q24672186-319911AD-2BD0-428C-8778-91D5469168D4 Q26768699-E58DA7A4-C9C9-4F31-BC7A-86854F1487DA Q26795657-E68134EA-9D7F-450A-ABD0-F120E1046468 Q26797347-5994155A-1F6C-4C3C-82DB-41D67C729D8C Q27678457-A2E771F1-1575-4393-8096-8C355449B8D1 Q27681807-1EE716C1-2B3D-4D56-8C39-8C0767380AEB Q28754728-DC3E83A6-FCAF-4D41-A97E-3C139CE4BFA5 Q33547424-CEE35E42-638A-4717-BF1D-77037C507071 Q33553298-57D72619-88BC-42AF-BC4F-1FE71041F372 Q34248566-0E93462E-1827-4C24-9D94-E3E8FF3B6194 Q34415144-87F708B8-FEB0-4797-BFF8-25DCD042D213 Q34440132-D1D9F61D-DECC-431F-A069-C4F9E0E996A8 Q34572848-13ED6FB3-4D41-48A7-A793-134A8800E981 Q34985362-FC6529F9-FF69-4D62-82D6-A91BBE3C1206 Q34987421-E6CC0817-78F8-4360-B768-EDDB46B35EDA Q35705387-95061977-DBB9-4736-96DF-E44574111844 Q36146922-2F1AB796-30AF-49E1-8AA4-B3E793555708 Q36228456-5F0DD6B1-AE58-4F7E-9130-5F465D4EE8C3 Q36749511-6CEB3655-B66C-4472-AC69-06AC01219D23 Q36835186-CF15AD3F-B1AB-40FF-A5A9-55C14ADC9717 Q37273190-CB4CF9A2-B79F-4404-8CA4-8299FFA90B24 Q37501797-6CC2250D-2D71-4A34-8622-43CD1C080C0B Q37525591-33158D83-953C-4840-8275-77A0FF391C22 Q37599571-91D1C0E7-6675-466C-A52F-12BDF00A787E Q37688877-9F63810A-5263-478C-93F5-367D0E08D7AA Q37828297-D6815C32-3B43-46D1-B481-14598FB9E62A Q37994621-EA54082F-FF22-4BA8-A573-B7047045D42C Q38020906-488422CF-9A03-4231-8BB8-135A75934175 Q38050484-6CA35CEA-78C3-4443-82A8-C7E1929E0762 Q38063960-1994C4CB-0FF3-4146-92FD-4D3DDB1DE8C0 Q38090560-5FDDD1EF-9B88-48D2-AEDD-EA7DB12B12CB Q38132851-A8C32C12-C325-4B46-84E7-5ADBFF5A5FCB Q38182585-649CDDD8-5382-4DE5-93D6-0A71F10C4648 Q38568857-941C9B33-699E-492B-AD8A-C88A4AD62870 Q38869731-6E13BA48-43ED-4F35-A3C6-426D2B42D9E5 Q38953250-A663C0A7-63B6-472F-8D16-7DBE61DA4418 Q39049093-695999AA-E0FC-44E9-BD5B-E7B2988C9176 Q39488232-979E9787-89AC-498E-AD2E-49D28D2E9E18 Q41903337-A406A50C-F28F-40D9-BD4D-C9DC3B2C0D2D

P2860

CD1d-restricted T cell activation by nonlipidic small molecules.

http://www.wikidata.org/entity/Q37535060

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2004

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

CD1d-restricted T cell activation by nonlipidic small molecules.

@en

CD1d-restricted T cell activation by nonlipidic small molecules.

@nl

type

label

CD1d-restricted T cell activation by nonlipidic small molecules.

@en

CD1d-restricted T cell activation by nonlipidic small molecules.

@nl

prefLabel

CD1d-restricted T cell activation by nonlipidic small molecules.

@en

CD1d-restricted T cell activation by nonlipidic small molecules.

@nl

P1433

Q37535060-B0E72671-9F95-4CA4-88D4-95551D2C55C9

P1476

Q37535060-60EA9A88-8042-4FC0-B97E-40F4A42FBC7E

P2093

Q37535060-07B75831-C9DF-4A3D-9D4D-465FB98D74B2

Q37535060-0F4E1665-7340-4138-9AA3-CCD3E24EEFB9

Q37535060-463772F4-9A95-4BB0-ACCF-227F32B6E8D5

Q37535060-934C4DA1-F668-4C7F-8F4E-E779B564CC5F

Q37535060-AE5D30DA-4040-4B0D-8BE2-87B936DDEF56

Q37535060-D986E9B8-8061-4A51-8D58-B6AB0995D3D3

P2860

Q37535060-0A6A3536-1C54-48A3-B006-4F82A61F42BA

Q37535060-16790F96-3768-4719-A1F1-87C119FE33D3

Q37535060-16808102-1C19-4E14-9783-03DDA53D307C

Q37535060-17C0E97F-30B4-4C25-B678-08168D23D443

Q37535060-1FD26EED-281B-44AE-8EDD-24482315E98F

Q37535060-1FEB619D-58D9-403A-B620-C0D26ABDE20E

Q37535060-2CCC88FF-827E-4E6C-A727-06B9A50A8B08

Q37535060-2D18E492-4CB7-4C0A-A503-16185BC4E8B5

Q37535060-2EBC7DD2-D0F3-4CA5-B545-CCA75EBEC478

Q37535060-3537427B-F1E9-45BF-8EF4-46C2059EC286

P304

Q37535060-A298F705-8ED3-48AA-B949-BE77BB144CE3

P31

Q37535060-1B3913EA-25EA-4420-9A15-734647842447

P356

Q37535060-FD29070B-C4F5-4D54-B0FB-E7A77884C44C

P407

Q37535060-E72A6C4C-EACA-469A-8635-375E7C581B1C

P433

Q37535060-33BA4D28-7B9E-4EE7-991F-D0A48EC9520B

P478

Q37535060-F9F9E7F4-4673-488C-A7AB-6D26EBF51C5C

P50

Q37535060-3A3800F1-A295-4FC7-A559-EA7B88E41081

Q37535060-48104431-844F-4754-A03F-2FD504F7A2F6

Q37535060-881CF4B4-10C5-4823-8478-38EA69AEDE16

Q37535060-E8C8C696-B07B-453A-94A1-34DE9C717836

P577

Q37535060-EC123BDE-813D-4B7C-BB67-E6D1D5F529EC

P5875

Q37535060-85BB5618-38DF-4680-845F-59589CDEEB57

P698

Q37535060-69B0FF55-2EE6-4A4E-ACA4-4396B9970657

P932

Q37535060-39EC9A01-7DFE-43EF-8969-22FEBCBB4B76

P356

PNAS.0402838101

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

CD1d-restricted T cell activation by nonlipidic small molecules.

@en

P2093

David C Young

http://www.w3.org/2001/XMLSchema#string

Jenny Gumperz

http://www.w3.org/2001/XMLSchema#string

Jin Seon Im

http://www.w3.org/2001/XMLSchema#string

Petr A Illarionov

http://www.w3.org/2001/XMLSchema#string

Steven B Levery

http://www.w3.org/2001/XMLSchema#string

Tan-Yun Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

An antimicrobial activity of cytolytic T cells mediated by granulysin

Structure of human CD1b with bound ligands at 2.3 A, a maze for alkyl chains

Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 A

The crystal structure of human CD1b with a bound bacterial glycolipid

Preferential usage of T-cell receptor V beta 17 by dengue virus-specific human T lymphocytes in a donor with immunity to dengue virus type 4

Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection

CD1-restricted T cell recognition of microbial lipoglycan antigens

Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol.

P304

13578-13583

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0402838101

http://www.w3.org/2001/XMLSchema#string

P407

P433

37

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Ildiko Van Rhijn

Steven A Porcelli

David Branch Moody

P577

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8369552

http://www.w3.org/2001/XMLSchema#string

P698

15342907

http://www.w3.org/2001/XMLSchema#string

P932

518797

http://www.w3.org/2001/XMLSchema#string